Key Takeaway: Travere Therapeutics has been honored with a bronze award by The Stevie Awards for Great Employers. This recognition underscores the company's efforts in creating a positive work environment. The Stevie Awards acknowledge outstanding employers worldwide, and Travere's achievement reflects its commitment to employee satisfaction.
Price reaction · baseline $13.18 (2023-09-19 close) · hit pre-market · 1 other TVTX headline(s) in the window, move may be shared
day 0 close · peak
-2.3%
Market Sentiment Analysis
POSITIVE FACTORS
Travere Therapeutics received a bronze award from The Stevie Awards.
Recognition highlights the company's commitment to fostering a great workplace.
The Stevie Awards celebrate top employers globally.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+79%
120-day peak, hindsight
Typical move
4.7%
average across 9 past catalysts
Lead asset
sparsentan
Phase 3 · Immunoglobulin A Nephropathy
Full Press Release Details
Thursday, September 20, 2023 —This week Travere Therapeutics was recognized once again by The Stevie Awards for Great Employers as a bronze award winner. The Stevies recognize some of the world’s best employers who help to create and foster great places to work . Read the full list of 2023 winners .
Frequently Asked Questions
What award did Travere Therapeutics receive?
Travere Therapeutics received a bronze award from The Stevie Awards.
What do The Stevie Awards recognize?
The Stevie Awards recognize some of the world's best employers.
When was the award announced?
The award was announced on September 20, 2023.
What is the significance of the award?
The award highlights Travere's commitment to fostering a great workplace.